Horich William Todd has officially filed a Form 3, which signifies his position as the Chief Commercial Officer at Supernus, Inc. This filing, dated November 4, 2026, is essential as it reflects Todd's commitment to his role within the company.

Supernus, Inc. is a pharmaceutical company focused on developing and commercializing innovative products for the treatment of central nervous system diseases. The company is based in Rockville, Maryland, and operates under the SIC classification of Pharmaceutical Preparations.

According to the filing, Todd did not own any securities of Supernus at the time he became subject to beneficial ownership reporting obligations. The filing states, "As of the time the Reporting Person became subject to beneficial ownership reporting obligations with respect to the Issuer, the Reporting Person did not beneficially own any securities of the Issuer." This indicates that Todd is starting his tenure without any prior ownership stake in the company.

This update may affect Supernus's stakeholders, including employees, investors, and partners, as it underscores the leadership structure within the organization. Todd's role as Chief Commercial Officer is crucial, especially in a competitive market where strategic direction and commercial success are vital.

The filing does not say what happens next, but it reinforces Todd's position and responsibilities within Supernus as the company continues to advance its pharmaceutical initiatives.